1. Directory
  2. New York
  3. New York
  4. Alzheimers Drug Discovery Foundation (ADDF)
EIN 20-1082179

Alzheimers Drug Discovery Foundation (ADDF)

IRS 501(c) type
501(c)(3)
Num. employees
47
City
New York
State
New York
Year formed
2004
Most recent tax filings
2023-12-01
NTEE code, primary
F01: Mental Health and Crisis Intervention Alliances and Advocacy
Description
The Alzheimer's Drug Discovery Foundation's mission is to rapidly accelerate the discovery of drugs to prevent, treat and cure Alzheimer's disease.
Total revenues
$37,742,020
2023
Total expenses
$61,943,588
2023
Total assets
$324,173,528
2023
Num. employees
47
2023

Program areas at ADDF

The Alzheimer's Drug Discovery Foundation is dedicated to rapidly accelerating the Discovery of drugs to prevent, treat and cure Alzheimer's disease and related dementias. The addf is solely focused on funding the development of drugs for alzheimer's, employing a venture philanthropy model to support research in academia and the biotech industry.

Grants made by ADDF

GranteeGrant descriptionAmount
Lifespan Extension Advocacy FoundationAlzheimers Research$5,750,000
Davos Alzheimer's CollaborativeAlzheimers Research$2,500,000
Cleveland ClinicAlzheimers Research$1,828,343
...and 10 more grants made

Who funds Alzheimers Drug Discovery Foundation (ADDF)

Grants from foundations and other nonprofits
GrantmakerDescriptionAmount
Fidelity Investments Charitable Gift FundFor Grant Recipient's Exempt Purposes$2,166,530
Dagmar Dolby FundSupport Addf's Biomarker Project$1,000,000
Association for Frontotemporal Degeneration (AFTD)Addf/aftd Drug Discovery Program and Treat Aftd Programs$700,000
...and 122 more grants received totalling $10,258,115

Personnel at ADDF

NameTitleCompensation
Mark RoithmayrChief Executive Officer$619,606
Karen HarrisChief Financial Officer and Head of Mission Relate$366,749
Jane McIntoshChief External Affairs and Philanthropy Officer$359,470
Howard FillitExecutive Director$632,502
Laura NisenbaumExecutive Director , Drug Dev. / Executive Director , Drug Development$434,157
...and 2 more key personnel

Financials for ADDF

RevenuesFYE 12/2023
Total grants, contributions, etc.$30,595,495
Program services$4,205,157
Investment income and dividends$3,119,289
Tax-exempt bond proceeds$0
Royalty revenue$0
Net rental income$0
Net gain from sale of non-inventory assets$644
Net income from fundraising events$-178,565
Net income from gaming activities$0
Net income from sales of inventory$0
Miscellaneous revenues$0
Total revenues$37,742,020

Form 990s for ADDF

Fiscal year endingDate received by IRSFormPDF link
2023-122024-11-14990View PDF
2022-122023-11-15990View PDF
2021-122022-11-15990View PDF
2020-122022-01-14990View PDF
2019-122021-04-05990View PDF
...and 10 more Form 990s
Data update history
April 20, 2025
Received grants
Identified 16 new grant, including a grant for $217,811 from The Goodnow Fund
January 15, 2025
Received grants
Identified 38 new grant, including a grant for $700,000 from Association for Frontotemporal Degeneration (AFTD)
January 3, 2025
Posted financials
Added Form 990 for fiscal year 2023
October 23, 2024
Received grants
Identified 11 new grant, including a grant for $400,000 from Lauder Foundation
August 10, 2024
Received grants
Identified 37 new grant, including a grant for $2,170,710 from Jewish Community Federation and Endowment Fund
Nonprofit Types
Grantmaking organizationsDisease research fundraisersMental health organizationsHeadquarter / parent organizationsCharities
Issues
HealthMental healthDiseases and disorders
Characteristics
Conducts researchFundraising eventsOperates internationallyNational levelGala fundraisersTax deductible donationsAccepts online donations
General information
Address
57 W 57th St 904
New York, NY 10019
Metro area
New York-Newark-Jersey City, NY-NJ-PA
County
New York County, NY
Website URL
alzdiscovery.org/ 
Phone
(212) 901-8000
Facebook page
TheADDF 
Twitter profile
@theaddf 
IRS details
EIN
20-1082179
Fiscal year end
December
Taxreturn type
Form 990
Year formed
2004
Eligible to receive tax-deductible contributions (Pub 78)
Yes
Categorization
NTEE code, primary
F01: Mental Health and Crisis Intervention Alliances and Advocacy
NAICS code, primary
813212: Health and Disease Research Fundraising Organizations
Parent/child status
Central organization
California AB-488 details
AB 488 status
May Operate or Solicit for Charitable Purposes
Charity Registration status
Current
FTB status revoked
Not revoked
AG Registration Number
CT0204769
FTB Entity ID
3623066
AB 488 data last updated ("as-of") date
2025-04-16
Free account sign-up

Want updates when ADDF has new information, or want to find more organizations like Alzheimers Drug Discovery Foundation (ADDF)?

Create free Cause IQ account
Cause IQ is a website that helps companies grow, maintain, and serve their nonprofit clients, and helps nonprofits find additional foundation funding. Our data and tools help professionals prospect for nonprofits, research opportunities, benchmark their clients, and enrich existing information.
Nonprofits
Product
Customers
About

© 2025 Nonprofit Metrics LLC
Terms of Service and Privacy Policy